Tempest Therapeutics Shares Are Trading Lower. The Company Announced Data From the Ongoing Global Randomized Phase 1b/2 Clinical Study for Amezalpat2.
Tempest Therapeutics Shares Are Trading Lower. The Company Announced Data From the Ongoing Global Randomized Phase 1b/2 Clinical Study for Amezalpat2.
Tempest Therapeutics的股票下跌了。該公司發佈了關於Amezalpat2全球隨機1b/2期臨床研究的最新數據。
Tempest Therapeutics Shares Are Trading Lower. The Company Announced Data From the Ongoing Global Randomized Phase 1b/2 Clinical Study for Amezalpat2.
Tempest Therapeutics的股票下跌了。該公司發佈了關於Amezalpat2全球隨機1b/2期臨床研究的最新數據。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。